A detailed history of First Dallas Securities Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, First Dallas Securities Inc. holds 18,580 shares of ABBV stock, worth $3.79 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
18,580
Previous 18,875 1.56%
Holding current value
$3.79 Million
Previous $3.44 Million 7.3%
% of portfolio
1.41%
Previous 1.58%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $45,663 - $53,324
-295 Reduced 1.56%
18,580 $3.19 Million
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $175,961 - $200,492
-1,101 Reduced 5.51%
18,875 $3.44 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $1.72 Million - $1.94 Million
12,528 Added 168.21%
19,976 $3.1 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $2 Million - $2.32 Million
-14,975 Reduced 66.78%
7,448 $1.11 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $583,309 - $725,889
-4,402 Reduced 16.41%
22,423 $3.02 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $40,056 - $46,131
277 Added 1.04%
26,825 $4.28 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $61,962 - $74,309
448 Added 1.72%
26,548 $4.29 Million
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $55,965 - $64,188
-417 Reduced 1.57%
26,100 $3.51 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $424,832 - $540,101
-3,087 Reduced 10.43%
26,517 $4.06 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $208,660 - $258,888
-1,581 Reduced 5.07%
29,604 $4.8 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $15,577 - $19,709
-145 Reduced 0.46%
31,185 $4.22 Million
Q3 2021

Oct 06, 2021

BUY
$106.4 - $120.78 $53,732 - $60,993
505 Added 1.64%
31,330 $3.38 Million
Q2 2021

Jul 06, 2021

SELL
$105.21 - $117.21 $15,255 - $16,995
-145 Reduced 0.47%
30,825 $3.47 Million
Q1 2021

May 26, 2021

SELL
$102.3 - $112.62 $19,846 - $21,848
-194 Reduced 0.62%
30,970 $3.35 Million
Q4 2020

Feb 01, 2021

BUY
$80.49 - $108.67 $26,320 - $35,535
327 Added 1.06%
31,164 $3.34 Million
Q3 2020

Oct 15, 2020

BUY
$85.91 - $100.83 $507,384 - $595,501
5,906 Added 23.69%
30,837 $2.7 Million
Q1 2020

May 04, 2020

BUY
$64.5 - $97.79 $22,833 - $34,617
354 Added 1.44%
24,931 $1.9 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $21,927 - $27,436
304 Added 1.25%
24,577 $2.18 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $303,248 - $364,591
4,815 Added 24.75%
24,273 $1.84 Million
Q2 2019

Aug 22, 2019

SELL
$65.7 - $83.98 $1.26 Million - $1.61 Million
-19,178 Closed
0 $0
Q1 2019

May 17, 2019

SELL
$77.14 - $90.79 $503,801 - $592,949
-6,531 Reduced 25.4%
19,178 $1.55 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $82,131 - $101,290
-1,055 Reduced 3.94%
25,709 $2.37 Million
Q3 2018

Oct 31, 2018

SELL
$88.91 - $98.84 $4,178 - $4,645
-47 Reduced 0.18%
26,764 $2.53 Million
Q2 2018

Jul 31, 2018

BUY
$89.78 - $106.23 $17,776 - $21,033
198 Added 0.74%
26,811 $2.48 Million
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $2.45 Million - $3.28 Million
26,613 New
26,613 $2.52 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $2.44 Million - $2.67 Million
-27,190 Closed
0 $0
Q3 2017

Nov 07, 2017

SELL
$69.85 - $89.22 $355,676 - $454,308
-5,092 Reduced 15.77%
27,190 $2.42 Million
Q2 2017

Aug 14, 2017

BUY
N/A
32,282
32,282 $2.34 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Dallas Securities Inc. Portfolio

Follow First Dallas Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Dallas Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Dallas Securities Inc. with notifications on news.